207 related articles for article (PubMed ID: 25724651)
61. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
62. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
63. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
[TBL] [Abstract][Full Text] [Related]
64. Potential role for antiangiogenic proteins in the myocardial infarction repair process.
Thompson JL; Ryan JA; Barr ML; Franc B; Starnes VA; Schwarz MA
J Surg Res; 2004 Jan; 116(1):156-64. PubMed ID: 14732363
[TBL] [Abstract][Full Text] [Related]
65. The effect of N-terminal changes on arginyl-tRNA synthetase from Escherichia coli.
Liu W; Liu MF; Xia X; Wang ED; Wang YL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):131-7. PubMed ID: 12007009
[TBL] [Abstract][Full Text] [Related]
66. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.
Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P
Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803
[TBL] [Abstract][Full Text] [Related]
67. Isolation and characterization of human nuclear and cytosolic multisynthetase complexes and the intracellular distribution of p43/EMAPII.
Wolfe CL; Warrington JA; Davis S; Green S; Norcum MT
Protein Sci; 2003 Oct; 12(10):2282-90. PubMed ID: 14500886
[TBL] [Abstract][Full Text] [Related]
68. Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation.
Feinstein M; Markus B; Noyman I; Shalev H; Flusser H; Shelef I; Liani-Leibson K; Shorer Z; Cohen I; Khateeb S; Sivan S; Birk OS
Am J Hum Genet; 2010 Dec; 87(6):820-8. PubMed ID: 21092922
[TBL] [Abstract][Full Text] [Related]
69. The significance of EMAP-II after allogeneic stem cell transplantation.
Nomura S; Ishii K; Shimizu M; Inami N; Uoshima N; Urase F; Maeda Y; Hayashi K
Transpl Immunol; 2009 May; 21(1):23-6. PubMed ID: 19565673
[TBL] [Abstract][Full Text] [Related]
70. Structure of Escherichia coli Arginyl-tRNA Synthetase in Complex with tRNA
Stephen P; Ye S; Zhou M; Song J; Zhang R; Wang ED; Giegé R; Lin SX
J Mol Biol; 2018 May; 430(11):1590-1606. PubMed ID: 29678554
[TBL] [Abstract][Full Text] [Related]
71. The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.
Haridas S; Bowers M; Tusano J; Mehojah J; Kirkpatrick M; Burnham DK
Cytokine; 2008 Nov; 44(2):304-9. PubMed ID: 18951814
[TBL] [Abstract][Full Text] [Related]
72. Serum endothelial monocyte-activating polypeptide-II: a novel biomarker in patients with non-small-cell lung cancer.
Sen E; Ulger F; Kaya A; Akar N; Gonullu U
Clin Lung Cancer; 2008 May; 9(3):166-70. PubMed ID: 18621627
[TBL] [Abstract][Full Text] [Related]
73. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
74. A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes.
Ko YG; Park H; Kim T; Lee JW; Park SG; Seol W; Kim JE; Lee WH; Kim SH; Park JE; Kim S
J Biol Chem; 2001 Jun; 276(25):23028-33. PubMed ID: 11292833
[TBL] [Abstract][Full Text] [Related]
75. AIMP1 negatively regulates adipogenesis by inhibiting PPARγ.
Kim JH; Lee JH; Park MC; Yoon I; Kim K; Lee M; Choi HS; Han JM; Kim S
J Cell Sci; 2014 Oct; 127(Pt 20):4483-93. PubMed ID: 25146391
[TBL] [Abstract][Full Text] [Related]
76. Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.
Zhou Z; Sun B; Huang S; Yu D; Zhang X
Cell Death Dis; 2020 Jul; 11(7):579. PubMed ID: 32709848
[TBL] [Abstract][Full Text] [Related]
77. Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E(2).
Battersby S; Boddy SC; Critchley HO; Jabbour HN
J Clin Endocrinol Metab; 2002 Aug; 87(8):3928-35. PubMed ID: 12161535
[TBL] [Abstract][Full Text] [Related]
78. Dimerization of Arginyl-tRNA Synthetase by Free Heme Drives Its Inactivation in Plasmodium falciparum.
Jain V; Yogavel M; Sharma A
Structure; 2016 Sep; 24(9):1476-87. PubMed ID: 27502052
[TBL] [Abstract][Full Text] [Related]
79. Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo.
Zhang F; Schwarz MA
Dev Dyn; 2000 Jul; 218(3):490-8. PubMed ID: 10878614
[TBL] [Abstract][Full Text] [Related]
80. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
